Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: a pilot study

Authors:

Abstract
Background. Tumour necrosis alpha has been implicated in the pathogenesis of autoimmune disorders was to evaluate the safety, tolerability and potential efficacy of the tumour necrosis factor alpha (TNF-α) inhibitor, etanercept (ET), in patients with idiopathic membranous nephropathy (MN).

This publication has 61 references indexed in Scilit: